Hostname: page-component-8448b6f56d-qsmjn Total loading time: 0 Render date: 2024-04-24T23:08:22.279Z Has data issue: false hasContentIssue false

Interstage somatic growth in children with hypoplastic left heart syndrome after initial palliation with the hybrid procedure

Published online by Cambridge University Press:  08 April 2016

Fiona T. S. Chan*
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Hannah R. Bellsham-Revell
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Hannah Duggan
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
John M. Simpson
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Tony Hulse
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
Aaron J. Bell
Affiliation:
Department of Congenital Heart Disease, Evelina London Children’s Hospital, London, United Kingdom
*
Correspondence to: F. T. S. Chan, Department of Congenital Heart Disease, Evelina London Children’s Hospital, Westminster Bridge Road, London SE1 7EH, United Kingdom. Tel: +44 020 7188 7188; Fax: +44 020 7188 4556; E-mail: F.Chan@nhs.net

Abstract

Introduction

The hybrid procedure is one mode of initial palliation for hypoplastic left heart syndrome. Subsequently, patients proceed with either the “three-stage” pathway – comprehensive second stage followed by Fontan completion – or the “four-stage” pathway – Norwood procedure, hemi-Fontan, or Fontan completion. In this study, we describe somatic growth patterns observed in the hybrid groups and a comparison primary Norwood group.

Methods

A retrospective analysis of patients who have undergone hybrid procedure and Fontan completion was performed. Weight-for-age and height-for-age z-scores were recorded at each operation.

Results

We identified 13 hybrid patients – eight in the three-stage pathway and five in the four-stage pathway – and 49 Norwood patients. Weight: three stage: weight decreased from hybrid procedure to comprehensive second stage (−0.4±1.3 versus −2.3±1.4, p<0.01) and then increased to Fontan completion (−0.4±1.5 versus −0.6±1.4, p<0.01); four stage: weight decreased from hybrid procedure to Norwood (−2.0±1.4 versus −3.3±0.9, p=0.06), then stabilised to hemi-Fontan. Weight increased from hemi-Fontan to Fontan completion (−2.7±0.6 versus −1.0±0.7, p=0.01); primary Norwood group: weight decreased from Norwood to hemi-Fontan (p<0.001) and then increased to Fontan completion (p<0.001). Height: height declined from hybrid procedure to Fontan completion in the three-stage group. In the four-stage group, height decreased from hybrid to hemi-Fontan, and then increased to Fontan completion. The Norwood group decreased in height from Norwood to hemi-Fontan, followed by an increase to Fontan completion.

Conclusion

In this study, we show that patients undergoing the hybrid procedure have poor weight gain before superior cavopulmonary connection, before returning to baseline by Fontan completion. This study identifies key periods to target poor somatic growth, a risk factor of morbidity and worse neurodevelopmental outcomes.

Type
Original Articles
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Stumper, O. Hypoplastic left heart syndrome. Postgrad Med J 2010; 86: 183188.Google Scholar
2. Brescia, AAB, Jureidini, SJ, Danon, SD, Armbrecht, EA, Fiore, ACF, Huddleston, CBH. Hybrid versus Norwood procedure for hypoplastic left heart syndrome: contemporary series from a single center. J Thorac Cardiovasc Surg 2014; 147: 17771782.CrossRefGoogle ScholarPubMed
3. Gibbs, JL, Wren, C, Watterson, KG, Hunter, S, Hamilton, JRL. Stenting of the arterial duct combined with banding of the pulmonary arteries and atrial septectomy or septostomy: a new approach to palliation for the hypoplastic left heart syndrome. Br Heart J 1993; 69: 551555.Google Scholar
4. Ringewald, JM, Stapleton, G, Suh, EJ. The hybrid approach – current knowns and unknowns: the perspective of cardiology. Cardiol Young 2011; 21: 4752.Google Scholar
5. Chai, PJC. Hybrid palliation for hypoplastic left heart syndrome: where do we stand now? J Thorac Cardiovasc Surg 2015; 149: 194.Google Scholar
6. Laranjo, S, Costa, G, Freitas, I, et al. The hybrid approach for palliation of hypoplastic left heart syndrome: intermediate results of a single-center experience. Rev Port Cardiol 2015; 34: 347355.CrossRefGoogle ScholarPubMed
7. Malik, S, Bird, TM, Jaquiss, RDB, Morrow, WR, Robbins, JM. Comparison of in-hospital and longer-term outcomes of hybrid and Norwood stage 1 palliation of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 2015; 150: 474480.e2.Google Scholar
8. Davidson, J, Gringras, P, Fairhurst, C, Simpson, J. Physical and neurodevelopmental outcomes in children with single-ventricle circulation. Arch Dis Child 2015; 100: 449453.Google Scholar
9. Burch, PT, Gerstenberger, E, Ravishankar, C, et al. Longitudinal assessment of growth in hypoplastic left heart syndrome: results from the single ventricle reconstruction trial. J Am Heart Assoc 2014; 3: e000079.Google Scholar
10. Anderson, JB, Kalkwarf, HJ, Kehl, JE, Eghtesady, P, Marino, BS. Low weight-for-age z-score and infection risk after the Fontan procedure. Ann Thorac Surg 2011; 91: 14601466.Google Scholar
11. Medoff-Cooper, B, Ravishankar, C. Nutrition and growth in congenital heart disease. Curr Opin Cardiol 2013; 28: 122129.Google Scholar
12. Feinstein, JA, Benson, DW, Dubin, AM, et al. Hypoplastic left heart syndrome. J Am Coll Cardiol 2012; 59: S1S42.Google Scholar
13. Anderson, JBAM, Iyer, SBIM, Schidlow, DNS, et al. Variation in growth of infants with a single ventricle. J Pediatr 2012; 161: 1621.e3.CrossRefGoogle ScholarPubMed
14. de Onis, M, Onyango, AW, Borghi, E, Siyam, A, Nishida, C, Siekmann, J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 2007; 85: 660667.CrossRefGoogle ScholarPubMed
15. Day, RW, Denton, DM, Jackson, WD. Growth of children with a functionally single ventricle following palliation at moderately increased altitude. Cardiology in the Young 2000; 10: 193200.Google Scholar
16. Miller-Tate, H, Stewart, J, Allen, R, et al. Interstage weight gain for patients with hypoplastic left heart syndrome undergoing the hybrid procedure. Congenit Heart Dis 2013; 8: 228233.Google Scholar
17. Cohen, MI, Bush, DM, Ferry, RJ, et al. Somatic growth failure after the Fontan operation. Cardiol Young 2000; 10: 447457.Google Scholar
18. Srinivasan, C. Impact of staged palliation on somatic growth in patients with hypoplastic left heart syndrome. Congenital Heart Disease 2010; 546551.Google Scholar
19. Vogt, KN, Manlhiot, C, Van Arsdell, G, Russell, JL, Mital, S, McCrindle, BW. Somatic growth in children with single ventricle physiology. J Am Coll Cardiol 2007; 50: 18761883.CrossRefGoogle ScholarPubMed
20. Ghanayem, NS, Tweddell, JS, Hoffman, GM, Mussatto, K, Jaquiss, RDB. Optimal timing of the second stage of palliation for hypoplastic left heart syndrome facilitated through home monitoring, and the results of early cavopulmonary anastomosis. Cardiol Young 2006; 16 (Suppl 1): 6166.Google Scholar
21. Fukui, S, Mitsuno, M, Yamamura, M, Ryomoto, M, Hao, H, Miyamoto, Y. Partial resection of cystic tumor of atrioventricular node. Ann Thorac Surg 2014; 98: 22232226.Google Scholar
22. Kelleher, DK, Laussen, P, Teixeira-Pinto, A, Duggan, C. Growth and correlates of nutritional status among infants with hypoplastic left heart syndrome (HLHS) after stage 1 Norwood procedure. Nutrition 2006; 22: 237244.Google Scholar
23. Leitch, CA, Karn, CA, Peppard, RJ, et al. Increased energy expenditure in infants with cyanotic congenital heart disease. J Pediatr 1998; 133: 755760.Google Scholar
24. Hehir, DA, Rudd, N, Slicker, J, et al. Normal interstage growth after the Norwood operation associated with interstage home monitoring. Pediatr Cardiol 2012; 33: 13151322.Google Scholar
25. Trabulsi, JC, Irving, SY, Papas, MA, et al. Total energy expenditure of infants with congenital heart disease who have undergone surgical intervention. Pediatr Cardiol 2015; 36: 16701679.Google Scholar
26. NICOR: National Institute for Cardiovascular Outcomes Research. Retrieved September 11, 2015, from https://nicor.nicor.org.uk.Google Scholar
27. Daymont, C, Neal, A, Prosnitz, A, Cohen, MS. Growth in children with congenital heart disease. Pediatrics 2013; 131: e236e242.Google Scholar
28. Slicker, J, Hehir, DA, Horsley, M, et al. Nutrition algorithms for infants with hypoplastic left heart syndrome; birth through the first interstage period. Congenit Heart Dis 2013; 8: 89102.Google Scholar
29. Jenkins, E. Feeding protocols for neonates with hypoplastic left heart syndrome. AACN Adv Crit Care 2015; 26: 215221.Google Scholar
30. Ghanayem, NS, Hoffman, GM, Mussatto, KA, et al. Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 2003; 126: 13671375.CrossRefGoogle ScholarPubMed
31. Cnota, JF, Hangge, PT, Wang, Y, et al. Somatic growth trajectory in the fetus with hypoplastic left heart syndrome. Pediatr Res 2013; 74: 284289.Google Scholar
32. Limperopoulos, C, Tworetzky, W, McElhinney, DB, et al. Brain volume and metabolism in fetuses with congenital heart disease: evaluation with quantitative magnetic resonance imaging and spectroscopy. Circulation 2010; 121: 2633.Google Scholar
33. Rhein von, M, Buchmann, A, Hagmann, C, et al. Severe congenital heart defects are associated with global reduction of neonatal brain volumes. J Pediatr 2015; 167: 12591263.e1.Google Scholar
34. Aguilar, DC, Raff, GW, Tancredi, DJ, Griffin, IJ. Childhood growth patterns following congenital heart disease. Cardiol Young 2014; 25: 10441053.Google Scholar
35. Avitabile, CM, Leonard, MB, Brodsky, JL, et al. Usefulness of insulinlike growth factor 1 as a marker of heart failure in children and young adults after the Fontan palliation procedure. Am J Cardiol 2015; 115: 816820.Google Scholar